Back to search

National and Kapodistrian University of Athens

Η μοριακή σταδιοποίηση με Multiplex PCR στο μελάνωμα

Abstract

dc:description

Malignant melanoma (MM) is a form of skin cancer originating from melanocytes (cells that produce the photoprotective pigment melanin). MM has a great metastatic potential via the lymphatic root or the bloodstream almost everywhere in the body, thus ranking as one of the most aggressive forms of cancer. Therefore, early diagnosis, accurate staging and appropriate therapy are essential for increasing life expectancy of melanoma patients. Prognosis of melanoma patients is based on histological data and the clinical image of the patients leading to misdiagnosis and downstaged subjects. Recently, the use of molecular markers has been tested for more precise staging of the disease. These markers may help diagnose early melanoma for better clinical management, better treatment follow-up, and more accurate detection of recurrence. Therefore, the detection of circulating melanoma cells (CMCs) in peripheral blood could screen-out patients with higher risk of relapse at the time of the diagnosis. The aims of this study are:• The design of a prognostic model for melanoma, using the detection of melanoma markers in blood specimens that may help reveal the minimal residual disease.• The correlation of CMCs detection with clinicopathological data, the prognosis (progression-free survival and overall survival) and the response to multiple protocols of treatment.• The creation of an easy and low cost technique that can be applied in any hospital lab to discriminate in a brief protocol, patients with subclinical residual disease.In this work, a group of melanoma specific markers has been studied that can be detected in mRNA samples from blood of melanoma patients. These markers were: tyrosinase (TYR), melanoma antigen recognized by T cells 1 (MELAN-A/MART-1), micropthalmia transcription factor isoform 4 (MITF-M) and GAPDH as internal control. A protocol has been set up to find the efficiency of our technique by spiking the melanoma cell line SK-MEL 28 cells in peripheral blood mononuclear cells (PBMCs) of healthy donors. Then a multiplex PCR protocol has been developed in which we could detect 1 SK-MEL 28 cell in 1.000.000 PBMCs for TYR and 1 SK-MEL 28 cell in 10.000.000 PBMCs for MART-1 and MITF-M. This protocol was tested in 81 melanoma patients of all stages in a blind study. Then the clinicopathological data of patients were collected correlated with our protocols’ results and statistic analysis was performed.The conclusions of this work are summarized as follows: the multiplex PCR protocol is correlated statistically with the stage of the disease as well as with the viability of patients. Specifically we can discriminate early staged patients from advanced staged patients with the number of markers that have been detected (p<0.001). Moreover the number of the markers detected correlates with survival or subclinical minimal residual disease that causes metastasis (p<0.01). We have set up a non interventional, low cost, easy and reliable protocol that could help the clinician to specify more accurately the stage of the disease and the prognosis of each patient.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2010

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Νέζος, Αδριανός
  • Nezos, Adrianos

Subjects

dc:subject × 19

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/28903

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Νέζος, Αδριανός; Nezos, Adrianos. Η μοριακή σταδιοποίηση με Multiplex PCR στο μελάνωμα. National and Kapodistrian University of Athens, 2010. http://hdl.handle.net/10442/hedi/28903